Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Alkermes-Data

More Like This

PR Newswire associated0

Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences

PR Newswire associated0

Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences

PR Newswire associated0

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society

PR Newswire associated0

Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)

PR Newswire associated0

Alkermes plc Reports First Quarter 2024 Financial Results

PR Newswire associated0

Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk

PR Newswire associated0

Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire associated0

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference